Each year, 290,000 to 650,000 people die from infections caused by the influenza A virus (IAV), with 3 to 5 million developing severe illnesses and the global economy losing $ 87.1 billion. Due to the high mutation rate of IAV, the threat of a new pandemic must be a severe risk to consider. All drugs approved against IAV infections focus on inhibiting the virus' mechanisms of replication and propagation. The ex...